Advancing Human Health

New Medical Technology Emerges from Quarter at Aggie Square Program

The Quarter at Aggie Square Biomedical Engineering cohort wrapped up their 10-week experience with a presentation of three medical prototypes for growth-accommodating heart valves, noninvasive glucose monitors and stroke-detection devices. The students chose the concepts to solve complex health challenges they encountered.

A Chip to Measure Immunity

Every winter, influenza returns with a new variant. People who have previously been infected with or vaccinated against flu may have some protection, but this depends on how well their immune system’s “memory” of the previous virus or vaccine cross-reacts with the new variant. At present, there is no good way to measure this.

Hyoyoung Jeong Named a 2024 Hellman Fellow

Jeong is one of 12 early-career faculty members who will receive a boost as this year's class of Hellman Fellows at UC Davis. The fellowship includes funding that will directly support Jeong's research into autonomous seizure management.

Advancing Alzheimer Research with AI

Professor Chen-Nee Chuah leads AI/ML efforts within a multidisciplinary team that has received a $6 million grant from the National Institute on Aging to deepen the understanding of the neuropathologic landscape of Alzheimer’s disease, focusing on individuals who identify as Hispanic/Latino.

Video Series Aims at Improving Indoor Air Quality

A new video series developed by experts at the UC Davis College of Engineering and California Department of Public Health aims to help building and facility managers better understand how to manage indoor air quality. Better indoor air quality can reduce the spread of airborne diseases such as COVID-19 and improve productivity in schools and workplaces.

UC Davis Receives Grant to Develop and Assess AI Approach for Atrial Fibrillation Risk Modeling

Atrial fibrillation, or AFib, is an irregular and often rapid heart rhythm, also known as an arrhythmia. AFib is the most common type of heart arrhythmia and predisposes patients to an increased risk of stroke. It has a significant global impact — affecting nearly 40 million individuals worldwide and over 6 million in the United States.